Role of BCR in the resistance of BCR/ABL harboring the T315I mutation

被引：0
|
作者：
Rafiei, A. [1 ]
Metodieva, A. T. [1 ]
Ottmann, O. G. [1 ]
Serve, H. [1 ]
Ruthardt, M. [1 ]
Mian, A. A. [1 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 2, Frankfurt, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [21] Computer Modeling and Synthesis of Potential Inhibitors of Tyrosine Kinase BCR-ABL with the T315I Mutation
    A. N. Fedarkevich
    O. L. Sharko
    V. V. Shmanai
    Russian Journal of Bioorganic Chemistry, 2020, 46 : 187 - 198
  • [22] Detection of BCR-ABL T315i Mutation in Imatinib Resistant Chronic Myeloid Leukemia Patients
    Mardziah, M.
    Salwati, S.
    Azlin, I
    Hafiza, A.
    Farisah, Noor A. R.
    Noraesah, M.
    Tumian, N. R.
    Wong, C. L.
    Azma, R. Z.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2019, 14 (01): : 145 - 156
  • [23] Inhibition of the drug-resistant T315I mutant of BCR-Abl
    Zhang, W.
    EJC SUPPLEMENTS, 2006, 4 (12): : 54 - 54
  • [24] Computer Modeling and Synthesis of Potential Inhibitors of Tyrosine Kinase BCR-ABL with the T315I Mutation
    Fedarkevich, A. N.
    Sharko, O. L.
    Shmanai, V. V.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2020, 46 (02) : 187 - 198
  • [25] In vitro and in vivo inhibition of the T315I mutant BCR/ABL kinase.
    Zhu, Hong
    Hanna, Ehab
    Lohse, Dan
    Stoughton, Silva
    Tam, Betty
    Barrett, Kathy
    Noronha, Glenn
    Dneprovskaia, Elena
    Cao, Jon
    Chow, Chun
    Hwang, Linda
    Mak, Chiching
    McPherson, Andy
    Palanki, Moorthy
    Pathak, Ved P.
    Renick, Joe
    Soil, Richard
    Zeng, Binqi
    Hood, John
    BLOOD, 2006, 108 (11) : 619A - 619A
  • [26] The molecular signature of BCR::ABL P210 and BCR::ABL T315I in a Drosophila melanogaster chronic leukemia model
    Baassiri, Amro
    Ghais, Ali
    Kurdi, Abdallah
    Rahal, Elias
    Nasr, Rihab
    Shirinian, Margret
    ISCIENCE, 2024, 27 (04)
  • [27] I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition
    Gao, Congying
    Zhang, Lei
    Xu, Yun
    Ma, Xiangyu
    Chen, Peilei
    Chen, Zhe-Sheng
    Wei, Liuya
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [28] S116836 overcomes BCR-ABL T315I mutation mediated imatinib resistance in chronic myeloid leukemia
    Gupta, Pranav
    Zhang, Guannan
    Barbuti, Anna Maria
    Ding, Ke
    Pan, Jingxuan
    Druker, Brian J.
    Chen, Zhe-Sheng
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Cleavage of BCR–ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR–ABL leukemic cells
    J E Kim
    S Yoon
    B-R Choi
    K P Kim
    Y-H Cho
    W Jung
    D-W Kim
    S Oh
    D-E Kim
    Leukemia, 2013, 27 : 1650 - 1658
  • [30] Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation
    Nicolini, Franck E.
    Hayette, Sandrine
    Corm, Selim
    Bachy, Emmanuel
    Bories, Dominique
    Tulliez, Michel
    Guilhot, Francois
    Legros, Laurence
    Maloisel, Frederic
    Kiladjian, Jean-Jacques
    Mahon, Francois-Xavier
    Quoc-Hung Le
    Michallet, Mauricette
    Roche-Lestienne, Catherine
    Preudhomme, Claude
    HAEMATOLOGICA, 2007, 92 (09) : 1238 - 1241
12345